.Attributes Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint asks for introduction of individuals along with MASLD as well as measurement of liver end results in cardio-- renal-- metabolic tests, when information recommend mechanistically tenable benefits as well as scientific safety-- as well as summarizes points to consider for test design and regulatory approval.